Cannabit
July 1, 2018
The FDA last week approved UK-based GW Pharmaceuticals’ Epidiolex, a “pure plant-derived CBD” extract shown to drastically reduce seizures in children with epileptic syndromes. Marking the […]
June 24, 2018
More than a dozen states are expected pass new cannabis legalization measures before 2025. Of them, four are expected to open medical markets, while nine may […]
June 24, 2018
By J.J. McCoy, Senior Managing Editor for New Frontier Data Judging by a flurry of anxious headlines this month, the U.S. Congress (with President Trump’s “probable” […]
June 19, 2018
By Yona Torres, Editor, New Frontier Data As exiting opportunities arise from the Canadian cannabis market, investors should be aware of five key risks and exposures […]
June 17, 2018
$23.9 billion The top 10 publicly traded U.S. cannabis companies are valued at $8.2 billion collectively, (CAD 23.9 billion), as illustrated here last week. Scotts Miracle-Gro […]
June 17, 2018
By Jordan Wellington, Simplyfya Cofounder and Chief Compliance Officer In many ways, working as a budtender is similar to working at other types of retail establishments. […]
June 17, 2018
By J.J. McCoy, Senior Managing Editor for New Frontier Data After long debate, a fair amount of drama, and a mandate to fulfill Prime Minister Justin […]
June 10, 2018
With Canada poised to be the first G-7 country to fully legalize cannabis, investors have been actively seeking to capitalize on the unique opportunity. Canadian companies […]
June 3, 2018
By J.J. McCoy, Senior Managing Editor for New Frontier Data Even before this year’s watershed event of the opening of California’s adult-use market, the U.S. legal […]